We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Cloud-Based Clinical Research Solutions Provider Announces Acquisition of Pioneering Medical IT Company

By MedImaging International staff writers
Posted on 10 Apr 2016
Medidata (New York, NY, USA), a leading global cloud-based solutions provider for clinical research has acquired Intelemage (Cincinnati, OH, USA) a global medical image sharing and workflow management company.

Medical imaging data is the fastest growing and largest source of data in the healthcare industry and cloud storage provides users with an end-to-end solution for capturing, managing, and analyzing their medical imaging data.

Under the transaction Medidata will integrate Intelemage technology into the Medidata Clinical Cloud, a Software as a Service (SaaS) platform.

Intelemage operates in 85 countries, and in more than 5,000 locations around the world, and provides tools for capturing medical imaging data, workflow management. The tools are used in clinical trials, hospitals, life sciences companies, research institutions, doctors, and core labs. The tools provide a single environment for managing all imaging activities, a high level of data control and access, and performance metrics.

Nicholas Wharton, Intelemage customer, and partner, and co-founder and VP of Medical Metrics, said, “Using Intelemage’s medical imaging technology has given us the ability to seamlessly capture data, streamline workflows and transfer imaging datasets securely, compliantly and reliably. At a time when clinicians and sponsors are increasingly turning to imaging-based biomarkers to detect and monitor disease and to assess the effectiveness of therapies, it’s exciting to see Intelemage join Medidata. The Medidata platform is transforming clinical research and—with the addition of Intelemage’s cutting-edge capabilities for global image sharing and management—is poised to play an even more significant role in driving the kind of medical innovation that will improve the lives of patients around the world.”

Related Links:

Medidata
Intelemage


Biopsy Software
Affirm® Contrast
Ultrasound Table
Women’s Ultrasound EA Table
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Adjustable Mobile Barrier
M-458

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.